# IndusAge Partners

> IndusAge Partners is a VC fund backing Software and Internet of Things. See 14 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Menlo Park, United States
- Total investments: 14
- Last investment: Sep 2021
- Lead investor: 36%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/indusage-advisors-limited
- X (Twitter): https://twitter.com/IndusAgeGlobal
- Website: https://www.indusage.com/
- Facebook: https://www.facebook.com/indusagecapital/

IndusAge Partners is an enterprise development firm & venture fund with capital, operational & go-to-market expertise to help innovation-led technology firms scale globally.IndusAge's Fund directs its Capital pooled from astute businessmen and financial institutions that represent individual savers’ funds towards building the nextgeneration of enterprises seeking to impact the world with their technology products and platforms.Their investors seek to make superior returns whilst accelerating changes through pervasive technologies. Walden Riverwood Ventures & IndusAge Partners combined and are now “WRVI Capital”.IndusAge also advises on Enterprise Innovation & ScaleUp providing a Persistent Outside-In view to their Client enterprises in a Cross-Functional way across their chosen Eight Vectors (Strategic Direction, Revenue Management, Operations, People, Financials, Technology, Step Change & GRC - governance, risk & compliance) to drive Sustainable Scale. Their team works across all vectors of company building and helps drive excellence that tangibly translates to business growth and enterprise value generation.

## Contacts

5 contacts available for IndusAge Partners. Shizune tracks 2 team members at IndusAge Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/indusage-partners?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 4 | 29% |
| Internet of Things | 3 | 21% |
| Apps | 1 | 7% |
| PaaS | 1 | 7% |
| SaaS | 1 | 7% |

29 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 5 | 36% |
| Seed | 3 | 21% |
| Series B | 3 | 21% |
| Series C | 1 | 7% |
| Funding Round | 1 | 7% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 7 | 50% |
| India | 3 | 21% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Sriram Viswanathan | Founding Managing Partner | 38 | — |
| Sudhir Rao | Founder | 11 | https://shizune.co/investors/profile/sudhir-rao-3 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Stellapps | Stellapps designs dairy management software applications that leverage the power of technology to improve dairy supply chain parameters. The company's applications leverage the Internet of Things (IoT), big data, cloud, mobility and data analytics to improve agri-supply chain parameters, including milk production, milk procurement, cold chainanimal insurance and farmer payments, enabling dairy farms, dairy farmers and cooperatives to maximize profits while minimizing effort. | $18M | Series C | Sep 15, 2021 |  |
| Excision BioTherapeutics | Excision BioTherapeutics is a private company focused on developing advanced gene-editing therapeutics to address the medical need for the treatment of life-threatening diseases caused by viral infections. They develop gene-editing medicines that eradicate or disrupt viral genes in human patients. Their mission is to advance gene-editingtherapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world. | $60M |  | Feb 17, 2021 |  |
| Excision BioTherapeutics | Excision BioTherapeutics is a private company focused on developing advanced gene-editing therapeutics to address the medical need for the treatment of life-threatening diseases caused by viral infections. They develop gene-editing medicines that eradicate or disrupt viral genes in human patients. Their mission is to advance gene-editingtherapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world. | $60M | Series A | Feb 02, 2021 |  |
| Clairvolex | Clairvolex is an IP Solutions company and our delivery model that combines deep IP domain, process innovation and custom-built IP tools are our key differentiators.Our consultative approach embedded with innovative tools and its wide acceptance by our global clientele stands as a testament to it. Our client base spreads across hi-tech and lifesciences industry covering all the diverse streams. Through partnership engagements we support our clients in developing, managing and monetizing their end-to-end patent portfolio and patent assets. With operations in multiple geographies, we have a state of the art infrastructure and a specialist team of engineers, scientists, attorneys and paralegals, trained to deliver high quality customized IP solutions. | $2M | Debt Financing | Sep 22, 2020 |  |
| Clairvolex | Clairvolex is an IP Solutions company and our delivery model that combines deep IP domain, process innovation and custom-built IP tools are our key differentiators.Our consultative approach embedded with innovative tools and its wide acceptance by our global clientele stands as a testament to it. Our client base spreads across hi-tech and lifesciences industry covering all the diverse streams. Through partnership engagements we support our clients in developing, managing and monetizing their end-to-end patent portfolio and patent assets. With operations in multiple geographies, we have a state of the art infrastructure and a specialist team of engineers, scientists, attorneys and paralegals, trained to deliver high quality customized IP solutions. | $3.5M | Series B | Jun 26, 2019 |  |
| Stellapps | Stellapps designs dairy management software applications that leverage the power of technology to improve dairy supply chain parameters. The company's applications leverage the Internet of Things (IoT), big data, cloud, mobility and data analytics to improve agri-supply chain parameters, including milk production, milk procurement, cold chainanimal insurance and farmer payments, enabling dairy farms, dairy farmers and cooperatives to maximize profits while minimizing effort. | $14M | Series B | May 31, 2018 |  |
| ParkourSC | Cloudleaf is a logistics and supply chain company that specializes in digital transformation, manufacturing, and pharmaceutical. It features a software platform that creates a digital twin of the supply chain and processes billions of events per second to deliver diagnostic and predictive insights in real-time for location, condition, utilizationand anomaly detection.The company was founded in 2014 and headquartered in Milpitas, California. | $13M | Series A | Sep 19, 2017 |  |
| ideaForge | ideaForge develops and produces Unmanned Aerial Systems that offer unmatched usability due to its user-centric innovations and design. With a focus on sustainable use in operation, it ensures the highest quality and performance of its products. It is in constant pursuit of creating products that inspire a new vision.Founded in 2007 by IIT Mumbaialumni Ankit Mehta, Rahul Singh, Vipul Joshi, and Ashish Bhat, IdeaForge is headquartered in Mumbai, India. | $10M | Series A | Dec 15, 2016 |  |
| Quadgen Wireless Solutions | Quadgen Wireless Solutions is a telecommunications company that offers network design and optimization services. | $21.9M | Series A | Jun 17, 2016 |  |
| Clairvolex | Clairvolex is an IP Solutions company and our delivery model that combines deep IP domain, process innovation and custom-built IP tools are our key differentiators.Our consultative approach embedded with innovative tools and its wide acceptance by our global clientele stands as a testament to it. Our client base spreads across hi-tech and lifesciences industry covering all the diverse streams. Through partnership engagements we support our clients in developing, managing and monetizing their end-to-end patent portfolio and patent assets. With operations in multiple geographies, we have a state of the art infrastructure and a specialist team of engineers, scientists, attorneys and paralegals, trained to deliver high quality customized IP solutions. |  | Series A | Nov 19, 2015 |  |

10 of 14 investments shown.

## Co-investors
- [Qualcomm Ventures](https://shizune.co/investors/profile/qualcomm-ventures) — VC Fund, 3 deals together
- [Celesta Capital](https://shizune.co/investors/profile/wrvi-capital) — VC Fund, 3 deals together
- [ABB Ventures](https://shizune.co/investors/profile/abb-technology-ventures) — VC Fund, 2 deals together
- [Adjuvant Capital](https://shizune.co/investors/profile/adjuvant-capital) — VC Fund, 2 deals together
- [Anzu Partners](https://shizune.co/investors/profile/anzu-partner) — VC Fund, 2 deals together
- [Artis Ventures](https://shizune.co/investors/profile/artis) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does IndusAge Partners invest in?

IndusAge Partners invests primarily in Software, Internet of Things and Apps startups, most often at Series A and Seed stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact IndusAge Partners?

Public channels for IndusAge Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at IndusAge Partners?

The team at IndusAge Partners includes Sriram Viswanathan (Founding Managing Partner) and Sudhir Rao (Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co